Advertisement
Screener

Monte Rosa Therapeutics, Inc. (GLUE) ROE

Monte Rosa Therapeutics, Inc. (GLUE) ROE

  • 2026-06-30: ROE -33.06%.
  • 2026-03-31: ROE -24.91%.
  • 2025-12-31: ROE -16.57%.
  • 2025-09-30: ROE 8.52%.

Complete source-backed roe history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-33.06%
2026-03-31-24.91%
2025-12-31-16.57%
2025-09-308.52%
2025-06-309.02%
2025-03-312.24%
2024-12-31-32.61%
2024-09-30-58.11%
2024-06-30-58.05%
2024-03-31-88.70%
2023-12-31-75.51%
2023-09-30-72.01%
2023-06-30-58.65%
2023-03-31-47.84%
2022-12-31-39.98%
2022-09-30-34.75%
2022-06-30-31.01%
2022-03-31-26.27%
2021-12-31-21.28%
2021-09-30-19.00%
2021-06-30-15.95%
2021-03-3172.35%
2020-12-3173.63%

Annual ROE

DateROE
2025-12-31-16.57%
2024-12-31-32.61%
2023-12-31-75.51%
2022-12-31-39.98%
2021-12-31-21.28%
2020-12-3173.63%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cullinan Therapeutics, Inc. (CGEM)United States$0.993B-5.72
Odyssey Therapeutics, Inc. (ODTX)United States$0.960B
MeiraGTx Holdings plc (MGTX)United States$1.061B16.10
Vor Biopharma Inc. (VOR)United States$1.091B1.60
Sana Biotechnology, Inc. (SANA)United States$0.886B-4.92
Candel Therapeutics, Inc. (CADL)United States$0.885B-8.86
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Replimune Group, Inc. (REPL)United States$1.186B-3.13
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10